semaglutide 0.75 GLP-1s This can contribute to weight loss by reducing the amount of food consumed and by promoting feelings of satiety (fullness) Semaglutide prevents cardiovascular events regardless

Patients with morbid obesity and GLP-1 receptor agonist exposure also had a significantly lower risk for exacerbations compared with those without exposure (risk difference, 13.3%

Evening training: Alpha GPC may help offset mental fatigue after long workdays

The STEP 1 trial extension followed 327 participants for a year after semaglutide and lifestyle intervention were both withdrawn

Patients in whom heart failure (HF) or chronic kidney disease (CKD) is prevalent, should receive a treatment intensification with an SGLT-2 inhibitor with the respective evidence from clinical studies due to the respective data (7072)